|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.095 AUD | +0.46% |
|
+0.46% | +22.35% |
| Mar. 25 | Proteomics International Signs Agreement with University of Oxford for Endometriosis Study | MT |
| Mar. 19 | Proteomics Says PromarkerD's US Launch Delayed | MT |
Proteomics International Laboratories Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported revenue was AUD 0.7748 million compared to AUD 0.650193 million a year ago. Net loss was AUD 4.03 million compared to AUD 3.16 million a year ago.
Basic loss per share from continuing operations was AUD 0.03 compared to AUD 0.03 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +22.35% | 93.47M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
PROTEOMICS INTERNATIONAL LABORATORIES LIMITED 
